PDCD4
Basic information
Region (hg38): 10:110871795-110900006
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PDCD4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 15 | 15 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 15 | 0 | 2 |
Variants in PDCD4
This is a list of pathogenic ClinVar variants found in the PDCD4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-110881291-G-A | Benign (Jun 06, 2018) | |||
10-110881394-C-T | not specified | Uncertain significance (Oct 25, 2022) | ||
10-110881416-C-T | not specified | Uncertain significance (Dec 13, 2021) | ||
10-110881428-G-T | not specified | Uncertain significance (Jan 26, 2023) | ||
10-110881439-G-A | not specified | Uncertain significance (May 04, 2022) | ||
10-110883009-C-T | not specified | Uncertain significance (Jun 07, 2023) | ||
10-110885317-C-A | not specified | Uncertain significance (Mar 30, 2024) | ||
10-110885328-C-A | not specified | Uncertain significance (May 20, 2024) | ||
10-110887670-G-A | not specified | Uncertain significance (Apr 07, 2022) | ||
10-110887846-A-T | not specified | Uncertain significance (Mar 14, 2023) | ||
10-110889623-C-G | not specified | Uncertain significance (Jan 04, 2024) | ||
10-110890623-T-G | not specified | Uncertain significance (Apr 23, 2024) | ||
10-110890645-A-G | not specified | Uncertain significance (Dec 01, 2022) | ||
10-110894099-G-C | not specified | Uncertain significance (Dec 22, 2023) | ||
10-110894119-T-C | not specified | Uncertain significance (Feb 13, 2024) | ||
10-110894182-A-G | not specified | Uncertain significance (Oct 13, 2023) | ||
10-110894445-A-G | not specified | Uncertain significance (Jan 19, 2024) | ||
10-110894480-C-T | Benign (May 21, 2018) | |||
10-110895964-A-G | not specified | Uncertain significance (Jul 05, 2023) | ||
10-110896009-C-G | not specified | Uncertain significance (Jul 25, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PDCD4 | protein_coding | protein_coding | ENST00000280154 | 11 | 28200 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.36e-7 | 0.938 | 125704 | 0 | 44 | 125748 | 0.000175 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.218 | 239 | 249 | 0.961 | 0.0000123 | 3063 |
Missense in Polyphen | 77 | 94.509 | 0.81474 | 1158 | ||
Synonymous | -0.177 | 92 | 89.9 | 1.02 | 0.00000467 | 891 |
Loss of Function | 1.83 | 14 | 23.6 | 0.593 | 0.00000116 | 318 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000403 | 0.000397 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000165 | 0.000163 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000204 | 0.000202 |
Middle Eastern | 0.000165 | 0.000163 |
South Asian | 0.000215 | 0.000196 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Inhibits translation initiation and cap-dependent translation. May excert its function by hindering the interaction between EIF4A1 and EIF4G. Inhibits the helicase activity of EIF4A. Modulates the activation of JUN kinase. Down-regulates the expression of MAP4K1, thus inhibiting events important in driving invasion, namely, MAPK85 activation and consequent JUN-dependent transcription. May play a role in apoptosis. Tumor suppressor. Inhibits tumor promoter-induced neoplastic transformation. Binds RNA (By similarity). {ECO:0000250, ECO:0000269|PubMed:16357133, ECO:0000269|PubMed:16449643, ECO:0000269|PubMed:17053147, ECO:0000269|PubMed:18296639, ECO:0000269|PubMed:19153607, ECO:0000269|PubMed:19204291}.;
- Pathway
- Proteoglycans in cancer - Homo sapiens (human);MicroRNAs in cancer - Homo sapiens (human);miR-targeted genes in lymphocytes - TarBase;miR-targeted genes in muscle cell - TarBase;miR-targeted genes in squamous cell - TarBase;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation;Interferon type I signaling pathways;mTOR signaling pathway
(Consensus)
Recessive Scores
- pRec
- 0.146
Intolerance Scores
- loftool
- 0.943
- rvis_EVS
- -0.16
- rvis_percentile_EVS
- 42.06
Haploinsufficiency Scores
- pHI
- 0.613
- hipred
- Y
- hipred_score
- 0.703
- ghis
- 0.503
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.877
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pdcd4
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; neoplasm; immune system phenotype; renal/urinary system phenotype; endocrine/exocrine gland phenotype;
Zebrafish Information Network
- Gene name
- pdcd4b
- Affected structure
- atrioventricular valve
- Phenotype tag
- abnormal
- Phenotype quality
- constricted
Gene ontology
- Biological process
- apoptotic process;cell aging;BMP signaling pathway;interleukin-12-mediated signaling pathway;negative regulation of apoptotic process;negative regulation of JUN kinase activity;negative regulation of cell cycle;negative regulation of transcription, DNA-templated;positive regulation of inflammatory response;epithelial to mesenchymal transition involved in cardiac fibroblast development;cellular response to lipopolysaccharide;negative regulation of cytokine production involved in inflammatory response;positive regulation of NIK/NF-kappaB signaling;negative regulation of vascular smooth muscle cell proliferation;negative regulation of myofibroblast differentiation;negative regulation of vascular smooth muscle cell differentiation;positive regulation of vascular associated smooth muscle cell apoptotic process;positive regulation of endothelial cell apoptotic process
- Cellular component
- nucleus;cytoplasm;cytosol
- Molecular function
- RNA binding;protein binding